Esophageal Disorders

JULY 24, 2020

The Role of Biomarkers In the Management of Barrett’s Esophagus

Potential to optimize therapy, surveillance, and screening

Ashton Ellison, MB ChB
Department of Medicine
Baylor University Medical Center
Dallas, Texas
Vani Konda, MD
Department of Medicine
Baylor University Medical Center
Baylor Scott and White Center of Esophageal Diseases
Dallas, Texas
Dr Ellison reported no relevant financial conflicts of interest. Dr Konda reported receiving grant support from Ironwood Pharmaceuticals.

It is well established that selected patients with high-grade dysplasia (HGD)/esophageal adenocarcinoma (EAC) benefit from endoscopic